BlackThorn Therapeutics
NEWS
BlackThorn Therapeutics was acquired by Neumora Therapeutics in 2020.
The week after the JP Morgan Healthcare Conference tends to be slower than the week of, and last week was no outlier. Still, there were clinical trial updates. Here’s a look.
With Backing from Google, J&J and Others, BlackThorn Raises $76 Million Series B.
Advances in data storage and processing, as well as biomarker identification, has led to cutting-edge breakthroughs in clinical and research imaging technology. Here’s a look at just a few of these stories.
IN THE PRESS